Smithkline Beecham Corp. v. Synthon Pharmaceuticals, Ltd.
311 F. App'x 323
Opinion
ON MOTION
ORDER
Upon consideration of Synthon Pharmaceuticals, Ltd. et al.’s unopposed motion to voluntarily dismiss their appeal,
IT IS ORDERED THAT:
(1) The motion is granted.
(2) Each side shall bear its own costs.
Free access — add to your briefcase to read the full text and ask questions with AI
Smithkline Beecham Corp. v. Synthon Pharmaceuticals, Ltd., 311 F. App'x 323 (Fed. Cir. 2008).
311 F. App'x 323 (Smithkline Beecham Corp. v. Synthon Pharmaceuticals, Ltd.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.